Key result
Recurrent depressive disorder is linked to ~3-fold higher cardiovascular disease prevalence versus healthy controls.
Why the study?
Does recurrent depressive disorder increase the prevalence of cardiovascular comorbidity, metabolic syndrome, and systemic low-grade inflammation compared to healthy controls?
Cross-Sectional (n=148)
No
Does recurrent depressive disorder increase the prevalence of cardiovascular comorbidity, metabolic syndrome, and systemic low-grade inflammation compared to healthy controls?
Patients with recurrent depressive disorders exhibit a significantly higher burden of cardiovascular comorbidity and systemic inflammation, highlighting the importance of integrated cardiometabolic screening in psychiatric care.
Answers are grounded in this paper and cite their sources.
Recurrent depressive disorder was associated with higher CVD and CRP; hypothesis-generating for cardiometabolic screening pending prospective trials.
AIM: To investigate the association between depression, metabolic syndrome (MBS), somatic, particularly cardiovascular comorbidity, and low-grade chronic inflammation assessed using C-reactive protein (CRP). METHODS: This cross-sectional study included 76 patients with recurrent depressive disorder (RDD) and 72 non-depressed medical staff controls from the Department of Psychiatry, University Hospital Center Zagreb between January 2011 and June 2012. RESULTS: Seventy-five percent of patients had somatic comorbidity. The most common comorbid conditions were cardiovascular disorders (46.1%), locomotor system diseases (35.5%), carcinoma (15.8%), thyroid diseases (9.2%), and diabetes (9.2%). MTB was more common in RDD patients (31.6%) than in controls (23.6%), but the difference was not significant. Elevated CRP was found to be significantly more frequent in patients with recurrent depressive disorders (RDD) (35.5%; χ(2) test, P=0.001, Cramer V=0.29) than in controls (12.5%) and was associated with lowered high-density lipoprotein and overweight/obesity. CONCLUSION: We found some intriguing links between stress, depression, metabolic syndrome, and low grade inflammation, which may be relevant for the prevalence of somatic comorbidity in patients with RDD, but further studies are needed to confirm our results.
No takes yet. Share an insight, caveat, or question.
Topić et al. (2013) conducted a cross-sectional in Recurrent depressive disorder (n=148). Recurrent depressive disorder vs. Non-depressed medical staff controls was evaluated on Cardiovascular diseases comorbidity (Cramer V 0.35, p=<0.001). Patients with recurrent depressive disorder had higher rates of cardiovascular diseases and elevated C-reactive protein compared to healthy controls.
Synapse has enriched 10 related papers. Consider them for comparative context: